EGR1 c.1213_1214delinsGC ;(p.F405A)

Variant ID: 5-137803351-TT-GC

NM_001964.2(EGR1):c.1213_1214delinsGC;(p.F405A)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics.

Antibodies (Basel, Switzerland)
Zhong, Xiaotian X; D'Antona, Aaron M AM
Publication Date: 2021-03-30

Variant appearance in text: 225: F405A
PubMed Link: 33808165
Variant Present in the following documents:
  • Main text
  • antibodies-10-00013.pdf
View BVdb publication page



Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.

Mabs
Lobner, Elisabeth E; Humm, Anne-Sophie AS; Mlynek, Georg G; Kubinger, Konstantin K; Kitzmüller, Michael M; Traxlmayr, Michael W MW; Djinović-Carugo, Kristina K; Obinger, Christian C
Publication Date: 2017-10

Variant appearance in text: 225: F405A
PubMed Link: 28816592
Variant Present in the following documents:
  • Main text
  • kmab-09-07-1364825.pdf
View BVdb publication page



The making of bispecific antibodies.

Mabs
Brinkmann, Ulrich U; Kontermann, Roland E RE
Publication Date: 2017

Variant appearance in text: 225: F405A
PubMed Link: 28071970
Variant Present in the following documents:
  • Main text
  • kmab-09-02-1268307.pdf
View BVdb publication page



Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG.

Mabs
Rose, Rebecca J RJ; van Berkel, Patrick H C PH; van den Bremer, Ewald T J ET; Labrijn, Aran F AF; Vink, Tom T; Schuurman, Janine J; Heck, Albert J R AJ; Parren, Paul W H I PW
Publication Date: 2013

Variant appearance in text: 225: F405A
PubMed Link: 23406897
Variant Present in the following documents:
  • mabs-5-219.pdf
View BVdb publication page